Transfusion dependence a barrier to quality end-of-life care for some with leukemia

December 12, 2017, American Society of Hematology

For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions, according to a new study being presented during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta. The study associates this reduced access and consequent diminished use of hospice services with a reduced quality of end-of-life care for these patients.

Building on previous research that correlated a longer duration of with increased quality of end-of-life care, this study analyzed additional factors that have been associated with poorer end-of-life care. These factors included the likelihood of dying in the hospital and the use of chemotherapy in the last two weeks of life, both of which are end-of-life quality measures advocated by the National Quality Forum, a leading voluntary consensus standards-setting organization.

Researchers found that, compared with patients who did not enroll in hospice care, those who did were far less likely to die in the hospital (3 percent vs 75 percent) or receive chemotherapy during the last two weeks of life (5 percent vs 16 percent). Additionally, they found that patients who needed periodic blood transfusions spent about half as much time in hospice care compared with leukemia patients who were not reliant on these transfusions.

"We found a significant association between transfusion dependence and less meaningful use of hospice care at the end of life among patients with leukemia," said Thomas W. LeBlanc, MD, associate professor of medicine at Duke Cancer Institute in Durham, NC, and senior author of the study. Transfusion-dependent patients were significantly more likely to spend fewer than three days in hospice care (27 percent) compared with patients who were not transfusion-dependent (19 percent), he said, associating longer time spent in hospice care with more meaningful use of the service.

According to Dr. LeBlanc, one of the barriers to the use of hospice care by transfusion-dependent patients with advanced leukemia is that many clinicians consider blood transfusions to be disease-modifying therapy rather than comfort care, as transfusions can help some patients to live longer and feel better. Another is that, under Medicare's reimbursement protocol, the cost of blood transfusions is not compensated separately, but must be covered within the per-diem rate paid for hospice care, reducing the ability of to provide transfusion support as part of their services. Furthermore, the logistical complexities of blood transfusion also often preclude providing the service in patients' homes, where most hospice patients receive care.

"These findings suggest that patients are having to choose between getting the transfusions they need and getting high-quality ," Dr. LeBlanc said.

In this study, Dr. LeBlanc, along with Adam J. Olszewski, MD, an assistant professor at Alpert Medical School of Brown University in Providence, RI, and colleagues reviewed data for 21,076 patients with acute or chronic leukemia who died more than 30 days after diagnosis. Patients were considered transfusion-dependent if, within 30 days before death or enrollment in hospice care, they received two or more blood transfusions at least five days apart. Patients' median age was 79.

Results showed that from 2001-2011, slightly more transfusion-dependent patients enrolled in hospice care than patients who were not transfusion-dependent (47 versus 43 percent), but that their median length of stay in hospice care was significantly shorter than those who were not transfusion-dependent (6 versus 11 days).

"This suggests that clinicians tend to enroll patients in hospice during the very last few days of life, but we know from other studies that the earlier patients enter hospice care, the more likely they are to obtain the full benefit of what hospice can offer in terms of an improved quality of life," said Dr. Olszewski, lead study author.

Doctors caring for patients with advanced leukemia who are transfusion-dependent often hesitate to suggest that a patient enter hospice care, said Dr. Olszewski, because doing so usually means having to terminate transfusion support. "Allowing patients to receive support as part of palliative care could transform the attitude of both patients and clinicians toward care," he added.

"Our findings suggest that allowing reimbursement for palliative transfusions in patients with terminal leukemia would be beneficial for both and their families," Dr. LeBlanc said.

Explore further: For leukemia patients, transfusion needs may delay hospice care

More information: Thomas W. LeBlanc, MD, will present the study "Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia [277]" on Saturday, December 9, at 4:00 p.m. EST in Room B302 of the Georgia World Congress Center.

Related Stories

For leukemia patients, transfusion needs may delay hospice care

December 9, 2017
Toward the end of life, some leukemia patients depend on blood transfusions to ease their suffering. Unfortunately, the likelihood that transfusions won't be accessible through hospice care appears to be pose a significant ...

Why fewer blood cancer patients receive hospice care

May 22, 2017
Research has shown that patients with blood cancers are less likely to enroll in hospice care than patients with solid cancers, and the findings from a national survey suggest that concerns about the adequacy of hospice may ...

Many Americans may get hospice care too late

November 3, 2014
(HealthDay)—Of the more than 1.5 million patients who received hospice care in the United States in 2013, one-third died within one week of getting it, a new report shows.

Does Medicare/Medicaid incentive payment affect home hospice care in last week of life?

July 17, 2017
A new study has shown that the new Service Intensity Add-on (SIA) payment for in-person routine home hospice care during the last 7 days of life, which was added to Medicare/Medicaid coverage in 2016, could increase visits ...

Five-year study sheds light on hospice care in assisted living facilities versus in the home

July 6, 2015
Researchers have found several key differences among people who receive hospice care—which maintains or improves the quality of life for someone whose condition is unlikely to be cured—in assisted-living facilities (ALFs) ...

Study compares hospice care in nursing homes, assisted living facilities and patient homes

March 23, 2017
A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found only minimal differences in the intensity of hospice services provided in nursing homes as compared to hospice services ...

Recommended for you

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

Researcher fighting breast cancer with light therapy

October 17, 2018
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.

New method uses just a drop of blood to monitor lung cancer treatment

October 17, 2018
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.